Allan Bradley
Allan Bradley
Senior Group Leader and Director Emeritus, Wellcome Trust Sanger Institute
Dirección de correo verificada de sanger.ac.uk
TítuloCitado porAño
A FULLY Human Bispecific Antibody Functionally Rescues Factor VIII Deficiency EX VIVO
W Wang, J Blackwood, R Magliozzi, L Moraes, J Hollins, A Sinopoli, B Chi, ...
Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019
2019
Methods, Cells & Organisms
A Bradley, H Ali, EC Lee
US Patent App. 16/516,996, 2019
2019
Animal Models and Therapeutic Molecules
A Bradley, EC Lee, Q Liang, W Wang, D Spensberger, H Liu, J Clube
US Patent App. 16/296,033, 2019
2019
A Genome-Wide Knockout Screen in Human Macrophages Identified Host Factors Modulating Salmonella Infection
ATY Yeung, YH Choi, AHY Lee, C Hale, H Ponstingl, D Pickard, ...
mBio 10 (5), e02169-19, 2019
2019
Expression vector production and high-throughput cell screening
A Bradley, EC Lee, Q Liang, H Liu, A Wood, V Wong
US Patent App. 16/407,560, 2019
2019
Animals, cells, ligands, polypeptides & methods
R Williams, EC Lee, A Bradley
US Patent App. 16/316,994, 2019
2019
THE FIRST MODEL OF FHR-ASSOCIATED C3 GLOMERULOPATHY DEMONSTRATES THE DIRECT PATHOGENICITY OF MUTANT FHR5 PROTEINS: 106
T Malik, D Lavin, D Gitterman, H Lomax-Browne, K Boroviak, A Bradley, ...
Molecular Immunology 114, 449-450, 2019
2019
Expression vector production and high-throughput cell screening
A Bradley, EC Lee, Q Liang, H Liu, A Wood, V Wong
US Patent 10,337,000, 2019
2019
High-throughput functional screening for PTEN-cooperating tumour suppressor networks in prostate cancer
J de la Rosa, A Bradley
FEBS OPEN BIO 9, 402-402, 2019
2019
Animal Models and Therapeutic Molecules
EC Lee, J Clube, A Bradley
US Patent App. 16/216,666, 2019
2019
DEVELOPMENT AND OPTIMISATION OF A FULLY HUMAN FVIII MIMETIC BISPECIFIC ANTIBODY FOR PATIENTS WITH HAEMOPHILIA A: PF338
W Wang, J Blackwood, R Magliozzi, L Moraes, A Fane-Dremucheva, ...
HemaSphere 3, 120-121, 2019
2019
A FULLY HUMAN BISPECIFIC ANTIBODY FUNCTIONALLY RESCUES FACTOR VIII DEFICIENCY EX VIVO: S851
W Wang, J Blackwood, R Magliozzi, L Moraes, A Sinopoli, B Chi, C Sellick, ...
HemaSphere 3, 379-380, 2019
2019
Genome-Scale CRISPRa Screen Identifies Novel Factors for Cellular Reprogramming
J Yang, SS Rajan, MJ Friedrich, G Lan, X Zou, H Ponstingl, DA Garyfallos, ...
Stem cell reports 12 (4), 757-771, 2019
52019
PiggyBac transposon tools for recessive screening identify B-cell lymphoma drivers in mice
J Weber, J de la Rosa, CS Grove, M Schick, L Rad, O Baranov, A Strong, ...
Nature communications 10 (1), 1415, 2019
22019
GIS and Data Tables for Focus Areas for Potential Domestic Nonfuel Sources of Rare Earth Elements
CL Dicken, JD San Juan, CA Anderson, AK Ayuso, RA Bern, ...
US Geological Survey, Southwest Region, 2019
2019
Animal models and therapeutic molecules
A Bradley, EC Lee, Q Liang, W Wang, D Spensberger, H Liu, J Clube
US Patent App. 10/226,033, 2019
2019
Simulating near field image in optical lithography
LI Jiangwei, Y Wang, J Liu
US Patent App. 10/209,615, 2019
12019
Apparatus and method for formation of multi-region articles
C Raleigh, MG Balles, CS Hubertz, K Wilcox
US Patent 10,207,440, 2019
92019
ATM orchestrates the DNA-damage response to counter toxic non-homologous end-joining at broken replication forks
G Balmus, D Pilger, J Coates, M Demir, M Sczaniecka-Clift, AC Barros, ...
Nature communications 10 (1), 87, 2019
112019
A resource of targeted mutant mouse lines for 5,061 genes
MC Birling, A Yoshiki, DJ Adams, S Ayabe, AL Beaudet, J Bottomley, ...
bioRxiv, 844092, 2019
2019
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20